Insider Selling: Arteris (NASDAQ:AIP) Director Sells $2,100,700.00 in Stock

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 70,000 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $30.01, for a total transaction of $2,100,700.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Saiyed Atiq Raza also recently made the following trade(s):

• On Wednesday, June 3rd, Saiyed Atiq Raza sold 20,839 shares of Arteris stock. The shares were sold at an average price of $37.39, for a total transaction of $779,170.21.
• On Monday, June 1st, Saiyed Atiq Raza sold 70,000 shares of Arteris stock. The stock was sold at an average price of $36.02, for a total transaction of $2,521,400.00.

Arteris Stock Performance

NASDAQ AIP opened at $29.78 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -34.23 and a beta of 1.96. The firm’s 50 day simple moving average is $35.94 and its 200 day simple moving average is $26.19. Arteris, Inc. has a 1 year low of $8.42 and a 1 year high of $50.26.

Arteris (NASDAQ:AIP) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The company had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. As a group, research analysts expect that Arteris, Inc. will post -0.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and set a $50.00 price target for the company in a report on Friday. Roth Capital began coverage on Arteris in a research note on Tuesday. They issued a “buy” rating and a $40.00 price objective on the stock. Rosenblatt Securities reiterated a “buy” rating and issued a $38.00 target price on shares of Arteris in a research report on Friday. Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Weiss Ratings cut shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Arteris presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.00.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of Arteris during the second quarter worth $160,129,000. Deutsche Bank AG bought a new position in shares of Arteris in the 2nd quarter valued at $1,767,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Arteris during the 2nd quarter valued at $53,000. Bank of New York Mellon Corp acquired a new stake in shares of Arteris during the 2nd quarter valued at $4,779,000. Finally, State of Wyoming bought a new stake in Arteris during the 2nd quarter worth $165,000. Institutional investors own 64.36% of the company’s stock.

Key Headlines Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
• Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
• Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
• Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
• Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.